UK markets closed

Actinium Pharmaceuticals, Inc. (ATNM)

NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
6.71+0.15 (+2.28%)
As of 02:21PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
1,053
81
1,030
1,144
0
Operating expenses
Research development
21,218
38,670
23,135
18,031
16,085
Selling general and administrative
10,696
13,331
11,999
8,077
6,308
Total operating expenses
31,914
52,001
35,134
26,108
22,393
Operating income or loss
-30,861
-51,920
-34,104
-24,964
-22,393
Income before tax
-30,380
-48,818
-33,017
-24,774
-22,215
Income from continuing operations
-30,380
-48,818
-33,017
-24,774
-22,215
Net income
-30,380
-48,818
-33,017
-24,774
-22,215
Net income available to common shareholders
-30,380
-48,818
-33,017
-24,774
-22,216
Basic EPS
-1.93
-1.83
-1.37
-1.20
-1.83
Diluted EPS
-1.93
-1.83
-1.37
-1.20
-1.83
Basic average shares
26,120
26,604
24,142
20,568
12,134
Diluted average shares
26,120
26,604
24,142
20,568
12,134